Trust CO Of Vermont Karyopharm Therapeutics Inc. Transaction History

Trust CO Of Vermont

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 22, 2021	SELL	$4.45 - $10.63 $1,780 - $4,252	-400 Closed	0 $0
Q2 2021 Jul 15, 2021	SELL	$8.11 - $11.11 $8,109 - $11,110	-1,000 Reduced 71.43%	400 $4,000
Q3 2020 Nov 06, 2020	SELL	$14.14 - $19.71 $8,484 - $11,826	-600 Reduced 30.0%	1,400 $20,000
Q1 2020 Apr 24, 2020	BUY	$14.38 - $27.72 $5,752 - $11,088	400 Added 25.0%	2,000 $38,000
Q2 2019 Jul 26, 2019	BUY	$4.32 - $6.43 $2,160 - $3,215	500 Added 45.45%	1,600 $10,000
Q1 2019 May 01, 2019	BUY	$4.12 - $10.25 $2,060 - $5,125	500 Added 83.33%	1,100 $7,000
Q4 2018 Jan 30, 2019	BUY	$8.2 - $16.95 $4,920 - $10,170	600 New	600 $6,000

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $70.2M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Trust CO Of Vermont, based on Form 13F filings with the SEC.

Stay updated on Trust CO Of Vermont with notifications on news.